Skip to main content
. 2024 Nov 19;150(12):507. doi: 10.1007/s00432-024-06024-6

Fig. 1.

Fig. 1

H&E and IHC staining of patients tumor tissue. Positive immunohistochemical staining for PD-L1 (a) and HER-2 (b) were tested in esophagocardial biopsy before neoadjuvant therapy. H&E staining were given after surgical resection for each patient after neoadjuvant therapy (c). Results are shown at × 400 magnification. IHC, immunohistochemical; PD-L1, programmed death ligand 1; HER2, human epidermal growth factor receptor 2